Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -7.87
- Piotroski Score 0.00
- Grade N/A
- Symbol (XRTX)
- Company XORTX Therapeutics Inc.
- Price $1.58
- Changes Percentage (-1.25%)
- Change -$0.02
- Day Low $1.58
- Day High $1.62
- Year High $67.72
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is based in Vancouver, Canada.
- Last Earnings 01/13/2014
- Ex-Dividend for 5/16 Dividend 01/31/2014
- Dividend Payable 02/17/2014
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.38
- Trailing P/E Ratio -1.73
- Forward P/E Ratio -1.73
- P/E Growth -1.73
- Net Income $-2,859,371
Income Statement
Quarterly
Annual
Latest News of XRTX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
XRTX Stock Price | XORTX Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
XORTX Therapeutics, Inc. is a biopharmaceutical company based in Calgary, Canada, focusing on developing innovative therapies for rare diseases like polycystic kidney disease and conditions related to...
By MarketWatch | 4 weeks ago